SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-061543
Filing Date
2024-03-07
Accepted
2024-03-07 08:49:02
Documents
16
Period of Report
2024-03-07
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750145d8k.htm   iXBRL 8-K 42557
2 EX-3.1 d750145dex31.htm EX-3.1 9827
3 EX-3.2 d750145dex32.htm EX-3.2 130120
  Complete submission text file 0001193125-24-061543.txt   335698

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amam-20240307.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20240307_lab.xml EX-101.LAB 18722
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20240307_pre.xml EX-101.PRE 11699
17 EXTRACTED XBRL INSTANCE DOCUMENT d750145d8k_htm.xml XML 3846
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 24728276
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)